(Q44751340)

5 December 2017

title

Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis (English)

1 reference

5 December 2017

Rizwan Moinuddin

1

1 reference

5 December 2017

Marcy deTineo

2

1 reference

5 December 2017

Barbara Maleckar

3

1 reference

5 December 2017

Robert M Naclerio

4

1 reference

5 December 2017

Fuad M Baroody

5

1 reference

5 December 2017

publication date

1 January 2004

1 reference

Annals of Allergy, Asthma & Immunology

5 December 2017

published in

1 reference

5 December 2017

volume

92

1 reference

5 December 2017

issue

1

1 reference

5 December 2017

page(s)

73-79

1 reference

Executive Summary of Joint Task Force Practice Parameters on Diagnosis and Management of Rhinitis.

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

1 reference

7 January 2021

The role of leukotrienes in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

7 January 2021

The role of leukotrienes in allergic rhinitis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

7 January 2021

Leukotriene C4 release in upper respiratory mucosa during natural exposure to ragweed in ragweed-sensitive children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

7 January 2021

Peptide Leukotriene Release after Antigen Challenge in Patients Sensitive to Ragweed

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

7 January 2021

Effect of desloratadine versus placebo on nasal airflow and subjective measures of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

7 January 2021

Complications of allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

7 January 2021

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

7 January 2021

Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

7 January 2021

Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

7 January 2021

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

7 January 2021

Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

7 January 2021

Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

7 January 2021

Assessment of nasal airway patency: a comparison of four methods.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

7 January 2021

Rethinking our approach to allergic rhinitis management

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

7 January 2021

A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

7 January 2021

Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

7 January 2021

Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

7 January 2021

Combined histamine H1 and H3 receptor blockade produces nasal decongestion in an experimental model of nasal congestion

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961713-9

7 January 2021

10.1016/S1081-1206(10)61713-9

Identifiers

DOI

1 reference

5 December 2017

1 reference